Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa05212 | Pancreatic cancer | 29/1765 | 76/8135 | 0.000777 | 0.003149 | 0.001971 | 29 | RABC10 | |
| KEGG | hsa04144 | Endocytosis | 76/1765 | 251/8135 | 0.0007848 | 0.003149 | 0.001971 | 76 | RABC10 | |
| KEGG | hsa04350 | TGF-beta signaling pathway | 34/1765 | 94/8135 | 0.0008859 | 0.003512 | 0.002198 | 34 | RABC10 | |
| KEGG | hsa04062 | Chemokine signaling pathway | 68/1364 | 192/8135 | 0.000000000199 | 0.0000000596 | 0.0000000385 | 68 | RABC85 | |
| KEGG | hsa04662 | B cell receptor signaling pathway | 38/1364 | 82/8135 | 0.000000000359 | 0.0000000596 | 0.0000000385 | 38 | RABC85 | |
| KEGG | hsa04064 | NF-kappa B signaling pathway | 44/1364 | 104/8135 | 0.000000000576 | 0.0000000638 | 0.0000000413 | 44 | RABC85 | |
| KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 41/1364 | 97/8135 | 0.00000000231 | 0.00000018 | 0.000000117 | 41 | RABC85 | |
| KEGG | hsa05416 | Viral myocarditis | 30/1364 | 60/8135 | 0.00000000271 | 0.00000018 | 0.000000117 | 30 | RABC85 | |
| KEGG | hsa04380 | Osteoclast differentiation | 49/1364 | 128/8135 | 0.00000000371 | 0.000000205 | 0.000000133 | 49 | RABC85 | |
| KEGG | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 41/1364 | 100/8135 | 0.00000000682 | 0.000000323 | 0.000000209 | 41 | RABC85 | |
| KEGG | hsa05144 | Malaria | 26/1364 | 50/8135 | 0.0000000108 | 0.000000449 | 0.00000029 | 26 | RABC85 | |
| KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 71/1364 | 222/8135 | 0.0000000124 | 0.000000458 | 0.000000296 | 71 | RABC85 | |
| KEGG | hsa05169 | Epstein-Barr virus infection | 66/1364 | 202/8135 | 0.0000000159 | 0.000000529 | 0.000000342 | 66 | RABC85 | |
| KEGG | hsa04640 | Hematopoietic cell lineage | 38/1364 | 99/8135 | 0.000000194 | 0.00000584 | 0.00000378 | 38 | RABC85 | |
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 35/1364 | 89/8135 | 0.000000294 | 0.00000814 | 0.00000526 | 35 | RABC85 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 35/1364 | 92/8135 | 0.000000751 | 0.0000189 | 0.0000122 | 35 | RABC85 | |
| KEGG | hsa04660 | T cell receptor signaling pathway | 38/1364 | 104/8135 | 0.000000838 | 0.0000189 | 0.0000122 | 38 | RABC85 | |
| KEGG | hsa04659 | Th17 cell differentiation | 39/1364 | 108/8135 | 0.000000853 | 0.0000189 | 0.0000122 | 39 | RABC85 | |
| KEGG | hsa04015 | Rap1 signaling pathway | 63/1364 | 210/8135 | 0.00000106 | 0.0000207 | 0.0000134 | 63 | RABC85 | |
| KEGG | hsa05221 | Acute myeloid leukemia | 28/1364 | 67/8135 | 0.00000106 | 0.0000207 | 0.0000134 | 28 | RABC85 | |
| KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 59/1364 | 194/8135 | 0.00000142 | 0.0000262 | 0.000017 | 59 | RABC85 | |
| KEGG | hsa05330 | Allograft rejection | 19/1364 | 38/8135 | 0.00000229 | 0.0000381 | 0.0000246 | 19 | RABC85 | |
| KEGG | hsa04514 | Cell adhesion molecules | 48/1364 | 149/8135 | 0.00000229 | 0.0000381 | 0.0000246 | 48 | RABC85 | |
| KEGG | hsa05165 | Human papillomavirus infection | 88/1364 | 331/8135 | 0.00000282 | 0.0000446 | 0.0000288 | 88 | RABC85 | |
| KEGG | hsa04668 | TNF signaling pathway | 38/1364 | 112/8135 | 0.00000663 | 0.0000944 | 0.0000611 | 38 | RABC85 | |
| KEGG | hsa05145 | Toxoplasmosis | 38/1364 | 112/8135 | 0.00000663 | 0.0000944 | 0.0000611 | 38 | RABC85 | |
| KEGG | hsa04060 | Cytokine-cytokine receptor interaction | 79/1364 | 295/8135 | 0.00000683 | 0.0000944 | 0.0000611 | 79 | RABC85 | |
| KEGG | hsa05140 | Leishmaniasis | 29/1364 | 77/8135 | 0.00000832 | 0.0001095 | 0.0000708 | 29 | RABC85 | |
| KEGG | hsa04151 | PI3K-Akt signaling pathway | 91/1364 | 354/8135 | 0.00000857 | 0.0001095 | 0.0000708 | 91 | RABC85 | |
| KEGG | hsa05205 | Proteoglycans in cancer | 59/1364 | 205/8135 | 0.00000984 | 0.000121 | 0.0000783 | 59 | RABC85 |